Seagen Inc Valuation
| SGENDelisted Stock | USD 196.23 2.04 1.05% |
At this time, the company appears to be overvalued. Seagen Inc has a current Real Value of $165.93 per share. The regular price of the company is $196.23. Our model measures the value of Seagen Inc from inspecting the company fundamentals such as Return On Equity of -0.28, operating margin of (0.35) %, and Shares Outstanding of 188.66 M as well as reviewing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Seagen's price fluctuation is very steady at this time. Calculation of the real value of Seagen Inc is based on 3 months time horizon. Increasing Seagen's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Seagen is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Seagen Stock. However, Seagen's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 196.23 | Real 165.93 | Hype 196.23 | Naive 199.34 |
The intrinsic value of Seagen's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Seagen's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Seagen Inc helps investors to forecast how Seagen stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Seagen more accurately as focusing exclusively on Seagen's fundamentals will not take into account other important factors: Seagen Total Value Analysis
Seagen Inc is at this time forecasted to have valuation of 42.06 B with market capitalization of 43.15 B, debt of 43.47 M, and cash on hands of 1.85 B. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Seagen fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
42.06 B | 43.15 B | 43.47 M | 1.85 B |
Seagen Investor Information
About 89.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 4.01. Seagen Inc last dividend was issued on the 30th of September 2010. Based on the analysis of Seagen's profitability, liquidity, and operating efficiency, Seagen Inc is not in a good financial situation at the moment. It has a very high risk of going through financial straits in December.Seagen Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Seagen has an asset utilization ratio of 53.41 percent. This suggests that the Company is making $0.53 for each dollar of assets. An increasing asset utilization means that Seagen Inc is more efficient with each dollar of assets it utilizes for everyday operations.Seagen Ownership Allocation
Seagen Inc shows a total of 188.66 Million outstanding shares. The majority of Seagen Inc outstanding shares are owned by institutional holders. These institutional investors are usually referred to as non-private investors looking to take positions in Seagen to benefit from reduced commissions. Consequently, institutions are subject to a different set of regulations than regular investors in Seagen Inc. Please pay attention to any change in the institutional holdings of Seagen Inc as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.Seagen Profitability Analysis
The company reported the previous year's revenue of 1.96 B. Net Loss for the year was (610.31 M) with profit before overhead, payroll, taxes, and interest of 207.99 M.About Seagen Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Seagen Inc. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Seagen Inc based exclusively on its fundamental and basic technical indicators. By analyzing Seagen's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Seagen's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Seagen. We calculate exposure to Seagen's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Seagen's related companies.Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. Seagen Inc. was incorporated in 1997 and is headquartered in Bothell, Washington. Seagen operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 2675 people.
Seagen Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 184.7 M | |
| Quarterly Earnings Growth Y O Y | 5.226 | |
| Forward Price Earnings | 909.0909 |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Consideration for investing in Seagen Stock
If you are still planning to invest in Seagen Inc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Seagen's history and understand the potential risks before investing.
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |